Skip to main content

FDA warns of serious manufacturing violations in letter to EpiPen manufacturing facility

A Pfizer unit that manufactures the EpiPen did not thoroughly investigate issues, including those associated with patient deaths and severe illness, the FDA said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.